|
|
|
|
在研适应症- |
|
最高研发阶段药物发现 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
The main objective of this randomized trial is to compare disease-free survival (DFS) in high risk leukemia patients who underwent haploidentical HCT followed by an add back strategy of HSV-Tk donor lymphocytes or standard haploidentical HCT
100 项与 p75NTR x 病毒胸苷激酶 相关的临床结果
100 项与 p75NTR x 病毒胸苷激酶 相关的转化医学
0 项与 p75NTR x 病毒胸苷激酶 相关的专利(医药)